Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pilot Study of Pasireotide LAR Treatment of Silent Corticotrophin Pituitary Tumors and Effects on Plasma Levels of POMC

NCT02749227 is registered in ClinicalTrials.gov with Columbia University as lead sponsor.

NCT NCT02749227
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02749227 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pilot Study of Pasireotide LAR Treatment of Silent Corticotrophin Pituitary Tumors and Effects on Plasma Levels of POMC
Lead sponsor
Columbia University
Phase
Phase 2
Overall status
Terminated
Start date
July 10, 2017
Completion date
March 31, 2020
Enrollment
4 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acth-producing pituitary tumour, pituitary tumor